Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artivion (AORT) Dividends Paid - Common (2012 - 2015)

Artivion posted quarterly Dividends Paid - Common of $855000.0 for Q4 2015, up 1.42% year-on-year from $843000.0 in Q4 2014, and little changed on a QoQ basis from $853000.0 in Q3 2015.

Artivion (AORT) has 4 years of Dividends Paid - Common data on file, last reported at $855000.0 in Q4 2015.

  • For the quarter ending Q4 2015, Dividends Paid - Common rose 1.42% year-over-year to $855000.0; the trailing twelve-month figure through Dec 2015 stood at $3.4 million (up 3.43% YoY), and the FY2015 full-year result was $3.4 million, up 3.43% from the prior year.
  • Dividends Paid - Common for Q4 2015 stood at $855000.0, roughly flat from $853000.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $855000.0 in Q4 2015 and bottomed at $687000.0 in Q4 2012.
  • The 4-year median for Dividends Paid - Common is $838000.0 (2014), against an average of $796692.3.
  • The widest annual swing landed in 2014, when Dividends Paid - Common gained 12.37%; it then gained 1.31% in 2015.
  • A 4-year view of Dividends Paid - Common shows it stood at $687000.0 in 2012, then increased by 11.35% to $765000.0 in 2013, then increased by 10.2% to $843000.0 in 2014, then grew by 1.42% to $855000.0 in 2015.
  • The last three Dividends Paid - Common figures came in at $855000.0 (Q4 2015), $853000.0 (Q3 2015), and $850000.0 (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.10 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 337.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 911.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 61.80 Mn
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2015 855,000.00
Dec 31, 2015 855,000.00
Sep 30, 2015 853,000.00
Sep 30, 2015 853,000.00
Jun 30, 2015 850,000.00
Jun 30, 2015 850,000.00
Mar 31, 2015 850,000.00
Mar 31, 2015 850,000.00
Dec 31, 2014 843,000.00
Dec 31, 2014 843,000.00
Sep 30, 2014 842,000.00
Sep 30, 2014 842,000.00
Jun 30, 2014 838,000.00
Jun 30, 2014 838,000.00
Mar 31, 2014 772,000.00
Mar 31, 2014 772,000.00
Dec 31, 2013 765,000.00
Dec 31, 2013 765,000.00
Sep 30, 2013 759,000.00
Sep 30, 2013 759,000.00
Jun 30, 2013 756,000.00
Jun 30, 2013 756,000.00
Mar 31, 2013 687,000.00
Mar 31, 2013 687,000.00
Dec 31, 2012 687,000.00
Dec 31, 2012 687,000.00